Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

2018/12/01 by Shoichi Maruyama, Hiroshi Ohtsu, Yasuo Ohashi +71 · 1 citation

paper · doi:10.1053/j.ajkd.2018.06.028

Cited by

• Dynamic Uric Acid Changes and Outcomes in CKD in the African American Study of Kidney Disease and Hypertension